Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues

Completed

Conditions studied: Glioblastoma, Malignant Solid Neoplasm

In brief

This study examines tumor tissues and blood samples to aid in the development of therapies for brain cancer and other solid tumors. Studying samples of blood and tissue from patients with glioblastoma or other solid tumor in the laboratory may help doctors understand brain tumors and better inform future treatments.

Key facts

Study ID

NCT04822688

Run by

Thomas Jefferson University

People needed

141

Starts

2021-02-03

Expected to finish

2025-06-30

Last updated by the study team

2026-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provide signed and dated informed consent form
• Any individual >= 18 years old
• Patients must have GBM or other solid tumor and undergoing surgery for diagnostic and therapeutic purposes

You may not qualify if…

• Individuals less than 18 years old
• Unable to understand and give consent
• Patients who are not surgical candidates

Where it is running

• Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.